...es its name from its first known site of origin, t... bound to anti-chymotrypsin (PSA-ACT) and other co... in patients with prostate cancer, benign prostati...tion, PSA serum levels appear to correlate with th...
Increase profitability by reducing chair time with simple test,sequences that can be administered by ancillary office staff in,less than 5 minutes. New Unsurpassed Homogenous Illumination.,Back
Contrast Sensitivity is Recognized as a Valuable Tool for Measuring Functional Vision Loss Caused by Early Eye Disease. Near Test F.A.C.T. 101: Size 5 in x 7 in (12.7cm x 17.78cm) Can be Hand-Held or
Adult: Letter Monocular Acuity, Binocular Astigmatism, Acuity Balance, Supression, Binocular Acuity, Fixation Desparity, Muscle Balance, Stereopsis
Medicine Products:(Date:12/2/2008)... A team of researchers from Monash University, The...dical School and Vanda Pharmaceuticals has found a...and sleep disorders caused by shift work. , Dr ... of Psychology, Psychiatry and Psychological Medic...in receptors in the brain, could be a highly effec...
(Date:12/2/2008)...atients given Trasylol have a higher death risk, d...althDay News) -- A new study casts more doubt on ...to limit bleeding in patients undergoing surgery. ...y in the United States, where it was removed from ...n and Australian researchers reviewed findings fro...
(Date:12/2/2008)...ANSING, Mich., Dec. 2 S...lth insurance companies gathered today to,oppose ...usiness legislation,through the lame duck session...ter of life or death for many of us in Michigan," ... Michigan Disability Rights,Coalition. "A vote fo...
(Date:12/2/2008)... (COLUMBUS, Ohio)Rare injuries accounted for 3.5 p...ugh 2007, according to the first study to examine ...thletes. Rare injuries include eye injuries, denta...tion and heat illness, which may result in high mo...ltering consequences. , Football was associated ...
Breaking Medicine News(10 mins):Health News:New medication brings hope of jet lag cure 2Health News:Another Study Warns of Risk From Cardiac Surgery Drug 2Health News:Opposition Continues to Grow to Blues' Legislation 2Health News:Opposition Continues to Grow to Blues' Legislation 3(Date:11/26/2008)...ROCHESTER, Minn., Nov. 26 /PRNewswire-USNewswire/ ...tward are at significantly increased risk of devel... to findings of a Mayo Clinic study published thi...e American Academy of Pediatrics. , , The r... 407 patients with strabismus (misaligned eyes) an...
(Date:11/26/2008)...Study Expanded to 406 Subjects , , FRANKLIN...tems Inc. (OTC Bulletin Board: PLCSF) announced to...S. Food and Drug Administration (FDA) for its U.S....ompany,s RenalGuard System(TM) and associated the...athy (CIN). , , The FDA also approved PLC,s...
(Date:11/25/2008)...LOUISVILLE, Ky., Nov. 25 /PRNewswire-USNewswire/ -...d surgeons performed the fifth U.S. hand transplan...ky, at Louisville,s Jewish Hospital Hand Care Cent...re began around noon and was completed shortly aft...o: http://www.newscom.com/cgi-bin/prnh/20081125/...
(Date:11/25/2008)...SOUTH SAN FRANCISCO, Calif., Nov. 25 /PRNewswire/ ... development of novel therapeutics that target,pr...e diseases, today,announced that data from two on...ultiple myeloma will be presented at the upcoming ...matology (ASH). Carfilzomib is the first in a new...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Elizabeth NJ Chosen for Alliance Merck Ciencia 28Science 29 Hispanic Scholars Program 20057 1Elizabeth NJ Chosen for Alliance Merck Ciencia 28Science 29 Hispanic Scholars Program 20057 2Elizabeth NJ Chosen for Alliance Merck Ciencia 28Science 29 Hispanic Scholars Program 20057 3Elizabeth NJ Chosen for Alliance Merck Ciencia 28Science 29 Hispanic Scholars Program 20057 4Elizabeth NJ Chosen for Alliance Merck Ciencia 28Science 29 Hispanic Scholars Program 20057 5Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market 20054 1Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market 20054 2ThalesNano Inc and sanofi aventis R 26D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time 5582 1ThalesNano Inc and sanofi aventis R 26D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time 5582 2Alsius Corporation Awarded Three Year Agreement with HealthTrust Purchasing Group 20051 1Alsius Corporation Awarded Three Year Agreement with HealthTrust Purchasing Group 20051 2Alsius Corporation Awarded Three Year Agreement with HealthTrust Purchasing Group 20051 3...AGO, June 04, 2007 /PRNewswire/ -- GlaxoSmithKline...dies of pazopanib in,advanced or metastatic renal ...ue sarcoma (STS). These trials were presented at t...Clinical Oncology,(ASCO) in Chicago. The results o...ther investigations. , Pazopanib is an oral, inves...
...LAND--(BUSINESS WIRE)--Jun 4, 2007 - Copernicus Th...eam at University of Oklahoma,Health Sciences Cent...gy, demonstrated that Copernicus, DNA nanoparticle...initis pigmentosa (RP). These,findings were presen...g in Seattle, WA. Mutations in genes important in ...
Other Medicine Technology:GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 2GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 3GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 4GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 5GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 6GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 7Vision Deficit in Retinitis Pigmentosa Mice Corrected with DNA,Nanoparticles 2